Geron Market Cap

Geron has a market cap or net worth of $962.28 million as of July 10, 2026. Its market cap has decreased by -0.60% in one year.

Market Cap

962.28M

Enterprise Value

745.26M

1-Year Change

-0.60%

Ranking

#2674

Market Cap Chart

Since December 1, 1998, Geron's market cap has increased from $159.40M to $962.28M, an increase of 503.69%. That is a compound annual growth rate of 6.72%.

Market Cap History

Date	Market Cap	% Change
Jul 10, 2026	962.30M	14.21%
Dec 31, 2025	842.60M	-60.62%
Dec 31, 2024	2.14B	86.74%
Dec 29, 2023	1.15B	24.20%
Dec 30, 2022	922.60M	134.88%
Dec 31, 2021	392.80M	-20.44%
Dec 31, 2020	493.70M	81.71%
Dec 31, 2019	271.70M	45.84%
Dec 31, 2018	186.30M	-35.00%
Dec 29, 2017	286.60M	-12.99%
Dec 30, 2016	329.40M	-56.99%
Dec 31, 2015	765.80M	49.89%
Dec 31, 2014	510.90M	-16.42%
Dec 31, 2013	611.30M	231.51%
Dec 31, 2012	184.40M	-5.24%
Dec 30, 2011	194.60M	-63.43%
Dec 31, 2010	532.20M	4.66%
Dec 31, 2009	508.50M	37.54%
Dec 31, 2008	369.70M	-13.62%
Dec 31, 2007	428.00M	-26.52%
Dec 29, 2006	582.50M	4.37%
Dec 30, 2005	558.10M	53.45%
Dec 31, 2004	363.70M	-6.72%
Dec 31, 2003	389.90M	337.60%
Dec 31, 2002	89.10M	-53.52%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Phathom Pharmaceuticals	1.00B
Janux Therapeutics	1.00B
Lexicon Pharmaceuticals	986.12M
Pharming Group	970.52M
DBV Technologies	964.84M
Annexon	950.29M
Design Therapeutics	948.72M
Arbutus Biopharma	948.18M

Market Cap Rankings